81: Neurodevelopmental Outcomes of Extremely Preterm Infants Treated with Bevacizumab for Severe Retinopathy of Prematurity
2021 ◽
pp. fetalneonatal-2020-320486
Keyword(s):
2021 ◽
pp. fetalneonatal-2020-319926
2017 ◽
Vol 54
(2)
◽
pp. 188-193
◽
Keyword(s):